These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 29283102)
1. Use of Vasodilators In Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review. Bravenboer de Sousa M; Cazemier S; Stegeman I; Thomeer H J Int Adv Otol; 2017 Dec; 13(3):399-403. PubMed ID: 29283102 [TBL] [Abstract][Full Text] [Related]
3. [A systematic review of vasodilators for sudden sensorineural hearing loss]. Wang M; Liu Y; Du Z; Zhu X; Luo G Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Oct; 24(19):869-71. PubMed ID: 21174745 [TBL] [Abstract][Full Text] [Related]
5. [Vasodilators for sudden sensorineural hearing loss: a systematic review of randomized controlled trials]. Gong Y; Liang C; Li J; Tian A; Chen N Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):64-8. PubMed ID: 12768798 [TBL] [Abstract][Full Text] [Related]
7. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Gouveris H; Selivanova O; Mann W Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):131-4. PubMed ID: 15747106 [TBL] [Abstract][Full Text] [Related]
9. Ethics of Placebo Control in Trials for Idiopathic Sudden Sensorineural Hearing Loss. Maldonado Fernández M; Kornetsky S; Rubio Rodriguez L Otolaryngol Head Neck Surg; 2016 Jul; 155(1):8-12. PubMed ID: 27371619 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid influence on prognosis of idiopathic sudden sensorineural hearing loss. Bogaz EA; Suzuki FA; Rossini BA; Inoue DP; Penido Nde O Braz J Otorhinolaryngol; 2014; 80(3):213-9. PubMed ID: 25153105 [TBL] [Abstract][Full Text] [Related]
11. N-Acetylcysteine combined with prednisolone treatment shows better hearing outcome than treatment with prednisolone alone for patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study. Kouka M; Bevern N; Bitter J; Guntinas-Lichius O Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):107-116. PubMed ID: 37392235 [TBL] [Abstract][Full Text] [Related]
12. Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis. Mirian C; Ovesen T JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):421-428. PubMed ID: 32163109 [TBL] [Abstract][Full Text] [Related]
13. Comparison of hearing recovery criteria in sudden sensorineural hearing loss. Inoue DP; Bogaz EA; Barros F; Penido Nde O Braz J Otorhinolaryngol; 2012 Jun; 78(3):42-8. PubMed ID: 22714846 [TBL] [Abstract][Full Text] [Related]
14. The effectiveness of hyperbaric oxygen in patients with idiopathic sudden sensorineural hearing loss: a systematic review. Eryigit B; Ziylan F; Yaz F; Thomeer HGXM Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):2893-2904. PubMed ID: 30324404 [TBL] [Abstract][Full Text] [Related]
15. Comparison of steroid administration methods in patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study. Kim SH; Jung SY; Kim MG; Byun JY; Park MS; Yeo SG Clin Otolaryngol; 2015 Jun; 40(3):183-90. PubMed ID: 25346100 [TBL] [Abstract][Full Text] [Related]
16. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis. Gao Y; Liu D Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3699-3711. PubMed ID: 27071771 [TBL] [Abstract][Full Text] [Related]
17. Oral steroid treatment for idiopathic sudden sensorineural hearing loss. Chen WT; Lee JW; Yuan CH; Chen RF Saudi Med J; 2015 Mar; 36(3):291-6. PubMed ID: 25737170 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for profound sudden idiopathic sensorineural hearing loss: a multicenter retrospective study. Lee HY; Kim DK; Park YH; Cha WW; Kim GJ; Lee SH Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):143-149. PubMed ID: 27544193 [TBL] [Abstract][Full Text] [Related]